type here...

CATEGORIES

Editors Choice

LATEST

1...130131132...150Page 131 of 150

TRENDING

EDITORS CHOICE

AI is Transforming Health Delivery: A Five-Year Reflection

Gil Bashe, Medika Life Editor -
Beyond Hype AI, ChatGPT and LLMs Are Practical Tools for Improved Care and Optimized Processes

A Digital Turning Point in Migraine Care: CT-132 FDA Approval to Market is a Win for Patients and Proof that Clinical Evidence Matters

Gil Bashe, Medika Life Editor -
First Digital Health App United States Approval for Migraine Treatment with a Comprehensive Indication of Use

Covid Patients in India Warned About Scammers Selling Fake Medicines and Cures

Medika Life -
Covid Patients in India are being sold fake medications, black market remdesivir and tocilizumab, by scammers. Here is how you can identify a scammer and stay safe.

“Investigational” Is Payer Code for “Coverage Denied”

Gil Bashe, Medika Life Editor -
Outside the pandemic, “investigational” remains payer code for denying reimbursement. In the case of treatment for chronic conditions, even FDA-approved digital-health and connected devices languish on waitlists for formulary inclusion.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories